These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 25068994)
21. Dicer loss and recovery induce an oncogenic switch driven by transcriptional activation of the oncofetal Imp1-3 family. JnBaptiste CK; Gurtan AM; Thai KK; Lu V; Bhutkar A; Su MJ; Rotem A; Jacks T; Sharp PA Genes Dev; 2017 Apr; 31(7):674-687. PubMed ID: 28446596 [TBL] [Abstract][Full Text] [Related]
22. IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis. Zhou Y; Huang T; Siu HL; Wong CC; Dong Y; Wu F; Zhang B; Wu WK; Cheng AS; Yu J; To KF; Kang W Mol Cancer; 2017 Apr; 16(1):77. PubMed ID: 28399871 [TBL] [Abstract][Full Text] [Related]
23. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression. Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594 [TBL] [Abstract][Full Text] [Related]
24. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of Mancarella C; Pasello M; Manara MC; Toracchio L; Sciandra EF; Picci P; Scotlandi K Front Endocrinol (Lausanne); 2018; 9():178. PubMed ID: 29731738 [TBL] [Abstract][Full Text] [Related]
25. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy. Humphries B; Yang C Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624 [TBL] [Abstract][Full Text] [Related]
26. Panebianco F; Kelly LM; Liu P; Zhong S; Dacic S; Wang X; Singhi AD; Dhir R; Chiosea SI; Kuan SF; Bhargava R; Dabbs D; Trivedi S; Gandhi M; Diaz R; Wald AI; Carty SE; Ferris RL; Lee AV; Nikiforova MN; Nikiforov YE Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2307-2312. PubMed ID: 28193878 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer. Hsu KF; Shen MR; Huang YF; Cheng YM; Lin SH; Chow NH; Cheng SW; Chou CY; Ho CL Br J Cancer; 2015 Jul; 113(3):414-24. PubMed ID: 26158423 [TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer. Cui XH; Hu SY; Zhu CF; Qin XH BMC Cancer; 2020 Nov; 20(1):1160. PubMed ID: 33246429 [TBL] [Abstract][Full Text] [Related]
29. Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer. Shi R; Yu X; Wang Y; Sun J; Sun Q; Xia W; Dong G; Wang A; Gao Z; Jiang F; Xu L Tumour Biol; 2017 Apr; 39(4):1010428317695928. PubMed ID: 28381175 [TBL] [Abstract][Full Text] [Related]
30. MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications. Lu YF; Zhang L; Waye MM; Fu WM; Zhang JF Exp Cell Res; 2015 May; 334(1):173-82. PubMed ID: 25857406 [TBL] [Abstract][Full Text] [Related]
31. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. Palanichamy JK; Tran TM; Howard JM; Contreras JR; Fernando TR; Sterne-Weiler T; Katzman S; Toloue M; Yan W; Basso G; Pigazzi M; Sanford JR; Rao DS J Clin Invest; 2016 Apr; 126(4):1495-511. PubMed ID: 26974154 [TBL] [Abstract][Full Text] [Related]
32. Non-coding RNAs as a new dawn in tumor diagnosis. Grimaldi A; Zarone MR; Irace C; Zappavigna S; Lombardi A; Kawasaki H; Caraglia M; Misso G Semin Cell Dev Biol; 2018 Jun; 78():37-50. PubMed ID: 28765094 [TBL] [Abstract][Full Text] [Related]
33. Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA. Mizutani R; Imamachi N; Suzuki Y; Yoshida H; Tochigi N; Oonishi T; Suzuki Y; Akimitsu N Oncogene; 2016 Jul; 35(27):3495-502. PubMed ID: 26522719 [TBL] [Abstract][Full Text] [Related]
34. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy. Mancarella C; Pasello M; Ventura S; Grilli A; Calzolari L; Toracchio L; Lollini PL; Donati DM; Picci P; Ferrari S; Scotlandi K Clin Cancer Res; 2018 Aug; 24(15):3704-3716. PubMed ID: 29703820 [No Abstract] [Full Text] [Related]
35. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5. Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115 [TBL] [Abstract][Full Text] [Related]
36. The biological function of IGF2BPs and their role in tumorigenesis. Du QY; Zhu ZM; Pei DS Invest New Drugs; 2021 Dec; 39(6):1682-1693. PubMed ID: 34251559 [TBL] [Abstract][Full Text] [Related]
37. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Koturbash I; Zemp FJ; Pogribny I; Kovalchuk O Mutat Res; 2011 Jun; 722(2):94-105. PubMed ID: 20472093 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma. Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663 [TBL] [Abstract][Full Text] [Related]
39. IGF2BPs as novel m Duan M; Liu H; Xu S; Yang Z; Zhang F; Wang G; Wang Y; Zhao S; Jiang X Genes Dis; 2024 Mar; 11(2):890-920. PubMed ID: 37692485 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis. Su Y; Xiong J; Hu J; Wei X; Zhang X; Rao L Oncotarget; 2016 Oct; 7(42):68397-68411. PubMed ID: 27588393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]